Email Updates

You are here

AVAC in the News

  • Internationally, HIV vaccine research and development (R&D) funding stood at $859 million last year, $9 million less than 2009, while China increased its spending by nearly US$4 million over the same period, said the global report issued jointly by international organizations including AIDS Vaccine Advocacy Coalition (AVAC) and Intentional AIDS Vaccine Initiative.

    September 15, 2011
  • The AIDS Vaccine 2011 conference ended Thursday in Bangkok, Thailand. While a vaccine to help end the pandemic remains elusive, scientific advances are being made. About 850 scientists, researchers and others met for four days to discuss progress on finding a vaccine to prevent HIV infection. It’s the only conference to focus exclusively on that.

    September 14, 2011
    Voice of America
  • The largest conference on AIDS vaccine development is being held in Bangkok, Thailand FROM September 12th to the 15th.  Researchers will discuss how to build on recent advances in a time of tight budgets. Organizers of the conference, known as AV-2011, say a “safe and effective AIDS vaccine would be one of the greatest public health advances ever.” But they also admit it’s one of the “greatest scientific challenges.”

    September 8, 2011
    Voice of America
  • Leading HIV prevention organizations have issued a call to action for the Department of Health and Human Services to develop a comprehensive plan of PrEP demonstration projects that identify how and where the intervention might best be used.

    August 25, 2011
    Bay Area Reporter
  • The world’s largest ongoing HIV vaccine study has been expanded to consider multiple ways a vaccine might boost immune response to the AIDS virus. The U.S. Institute of Allergy and Infectious Diseases (NIAID) is testing the safety and efficacy of a dual vaccine candidate.

    August 10, 2011
    Voice of America
  • This week the world has been looking back at 30 years of AIDS. Three decades have taken us from five young gay men in Los Angeles to 34 million men, women and children around the world living with HIV. But what about the next thirty years? Could we see an end to AIDS?

    June 9, 2011
    Huffington Post
  • In Kenya, clinical trials began on two promising new designs for preventive HIV vaccines. In South Africa, researchers launched clinical trials on a therapeutic vaccine intended to strengthen the immune systems of people living with HIV/AIDS.

    May 26, 2011
  • Last week the AIDS world received the stunningly encouraging results of an advanced-stage clinical trial known as “HPTN 052.”

    May 19, 2011
  • Millions of HIV infections could be averted by treating patients earlier than current guidelines recommend, after a study showed giving pills to patients as soon as they’re diagnosed can prevent them infecting others.

    May 13, 2011
  • The journal Science chose an AIDS study as the twenty-eleven "Breakthrough of the Year." The study found that antiretroviral drugs can greatly lower the risk of spreading HIV, the virus that causes AIDS. It showed that infected people with early treatment were ninety-six percent less likely to infect their partners.

    January 10, 2011
    Voice of America